|
Market Closed -
NYSE
04:00:03 2026-10-29 pm EDT
|
5-day change | 1st Jan Change | ||
| 330.53 USD | +1.91% |
|
-2.91% | -2.14% |
| Oct. 21 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| Oct. 21 | Baird Adjusts Price Target on Cencora to $375 From $373 | MT |
| Market Cap | 61.89B 55.31B 50.92B 46.24B 86.55B 5,893B 88.18B 609B 243B 3,088B 232B 227B 9,762B | P/E 2026 * |
18.1x | P/E 2027 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 69.33B 61.96B 57.04B 51.8B 96.95B 6,601B 98.77B 682B 272B 3,459B 260B 255B 10,936B | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.19x |
| Free-Float |
61.21% | Yield 2026 * |
0.72% | Yield 2027 * | 0.74% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
Mexican S.E.
| COR * | End-of-day quote | |
London S.E.
| 0HF3 | Delayed | |
Tradegate
| ABG | Real-time | |
Berne S.E.
| ABG | End-of-day quote | |
Boerse Muenchen
| ABG | Real-time | |
Xetra
| ABG | Delayed | |
Deutsche Boerse AG
| ABG | Delayed | |
Börse Stuttgart
| ABG | Delayed | |
Wiener Boerse
| ABC | End-of-day quote | |
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | +1.91% | ||
| 1 week | -2.91% | ||
| Current month | +10.08% | ||
| 1 month | +8.79% | ||
| 3 months | +3.43% | ||
| 6 months | +5.94% | ||
| Current year | -2.14% |
| 1 week | 320.06 | 338.07 | |
| 1 month | 295.01 | 345.46 | |
| Current year | 244.82 | 376.92 | |
| 1 year | 244.82 | 377.54 | |
| 3 years | 182.75 | 377.54 | |
| 5 years | 113.68 | 377.54 | |
| 10 years | 68.7 | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 2024-09-30 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 2026-06-28 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 2013-05-15 |
Robert Mauch
BRD | Director/Board Member | 59 | 2024-09-30 |
D. Mark Durcan
CHM | Chairman | 64 | 2025-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Other | Director | 275 | 0.0001% | ||
| 10/1/26 | Sell | Controller/Auditor | -986 | 0.0005% | ||
| 10/1/26 | Other | Director | 197 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.91% | -2.91% | -1.52% | +76.15% | 61.89B | ||
| +1.88% | +4.04% | -17.41% | +12.62% | 178B | ||
| +2.55% | +4.75% | -17.07% | +19.03% | 117B | ||
| +2.46% | +4.39% | +4.16% | +39.87% | 116B | ||
| +0.28% | +2.53% | -43.87% | +6.06% | 91.03B | ||
| -0.32% | -0.66% | +10.51% | +81.65% | 55.85B | ||
| +1.63% | +2.06% | +7.67% | -21.17% | 53.16B | ||
| +2.32% | +4.07% | -9.20% | +47.17% | 44.35B | ||
| +1.94% | +5.08% | -1.18% | -6.94% | 33.59B | ||
| +1.67% | -0.41% | +15.46% | -10.48% | 29.67B | ||
| Average | +1.53% | +0.65% | -5.25% | +24.40% | 77.98B | |
| Weighted average by Cap. | +1.44% | +1.13% | -9.85% | +24.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 301B 277B 252B 471B 32,089B 480B 3,315B 1,321B 16,817B 1,265B 1,238B 53,159B | 352B 314B 289B 263B 492B 33,484B 501B 3,459B 1,378B 17,548B 1,320B 1,292B 55,470B |
| Net income | 3.58B 3.2B 2.95B 2.67B 5.01B 341B 5.1B 35.21B 14.03B 179B 13.44B 13.15B 565B | 2.84B 2.54B 2.34B 2.13B 3.98B 271B 4.05B 27.98B 11.15B 142B 10.68B 10.45B 449B |
| Net Debt | 7.44B 6.65B 6.12B 5.56B 10.4B 708B 10.6B 73.14B 29.15B 371B 27.91B 27.32B 1,173B | 5.95B 5.31B 4.89B 4.44B 8.31B 566B 8.47B 58.48B 23.31B 297B 22.31B 21.84B 938B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | $330.53 | +1.91% | 1,015,307 |
| 26-10-28 | $324.35 | -0.31% | 1,076,740 |
| 26-10-27 | $325.37 | -1.40% | 1,123,060 |
| 26-10-26 | $330.00 | -0.30% | 993,480 |
| 26-10-23 | $331.00 | -2.21% | 1,168,293 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions

















